Extended Data Fig. 8
From: Anti-CD19 CAR T cells for pediatric patients with treatment-refractory autoimmune diseases
Hematotoxicity after zorpocabtagene-autoleucel infusion. Representation of early and late immune effector cell-associated hematotoxicity (ICAHT)62 in each patient treated with autologous zorpocabtagene-autoleucel.
